5 Panel T-Cup Urine Multi-Drug Test, CLIA Waived

SAFElife 5 Panel T-Cup Urine Multi-Drug Test is a self-contained urine drug screening cup that combines specimen collection and on-site testing in one device. Choose the configuration that fits your program: TDOA-154 screens for amphetamine, cocaine, opiates, phencyclidine, and marijuana/THC; TDOA-254 screens for amphetamine, cocaine, methamphetamine, opiates, and marijuana/THC. Each box contains 25 FDA 510(k)-cleared, CLIA-waived test cups.

Product Specifications

Brand	SAFElife
Available SKUs	TDOA-154 and TDOA-254
Test Format	T-Cup urine multi-drug test cup
TDOA-154 Panel	AMP1000-COC300-OPI2000-PCP25-THC50
TDOA-254 Panel	AMP1000-COC300-MAMP1000-OPI2000-THC50
Specimen Type	Urine
Result Time	Read at 5 minutes
Temperature Check	90–100°F acceptable; observe temperature strip between 2 and 4 minutes after collection
Quantity	25 test cups per box
Result Display	Line-based
Test Method	Rapid diagnostic test (RDT); point-of-care test
Classification	FDA 510(k) Cleared and CLIA Waived
Intended Setting	Professional workplace, clinical, occupational-health, correctional, forensic, and point-of-care screening programs

Key Features

• Two 5-panel configurations: Select AMP/COC/OPI/PCP/THC or AMP/COC/MAMP/OPI/THC based on your testing requirements.
• All-in-one urine test cup: Combines specimen collection and drug screening in a single self-contained device.
• Integrated temperature strip: Supports specimen-temperature verification between 2 and 4 minutes after collection.
• 90–100°F temperature range: An in-range temperature supports an acceptable specimen-temperature check.
• Minimum-fill line: Helps confirm the specimen reaches the required collection level.
• Peel-away result label: Provides access to easy-to-read, line-based result windows after collection.
• Rapid results: Provides preliminary screening results at 5 minutes.
• FDA 510(k)-cleared and CLIA-waived: Designed for eligible professional point-of-care testing settings.
• 25 test cups per box: Supports routine workplace, clinical, forensic, and occupational-health screening programs.

Simple Test Procedure

1. Collect the urine specimen directly in the test cup, ensuring it reaches the minimum fill line.
2. Recap the cup securely and place it on a clean, flat surface.
3. Observe the integrated temperature strip between 2 and 4 minutes after collection. A temperature of 90–100°F is acceptable; other readings may indicate a specimen-integrity concern.
4. Peel back the result label to expose the test-result window.
5. Read and interpret the drug-screen results at 5 minutes.

How to Interpret Results

Important: No meaning is attributed to test-line color, intensity, or width. A faint test line is still interpreted as a negative result. This screening device provides preliminary results; follow applicable program procedures for confirmation of presumptive positive results.

Frequently Asked Questions

What drugs do the available 5-panel T-Cup configurations detect?

TDOA-154 screens for amphetamine (AMP), cocaine (COC), opiates (OPI), phencyclidine (PCP), and marijuana/THC. TDOA-254 screens for amphetamine (AMP), cocaine (COC), methamphetamine (MAMP), opiates (OPI), and marijuana/THC.

How is specimen temperature checked?

Observe the integrated temperature strip between 2 and 4 minutes after collection. A temperature reading from 90–100°F is acceptable.

When should results be read?

After collecting the specimen, securely recapping the cup, and peeling back the result label, read and interpret results at 5 minutes.

How many test cups are included per box?

Each box contains 25 individual 5-panel urine drug test cups.

Is this product CLIA waived?

Yes. This product is FDA 510(k) cleared and CLIA waived for eligible professional point-of-care testing settings.

What does a faint test line mean?

A faint test line is interpreted as a negative result. Test-line color, intensity, and width do not change result interpretation.